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Macronutrients and cardiovascular risk in a global context
The evidence base and guidance on the consumption 
of dietary macronutrients for health has come a long 
way. This evolution includes a shift from a historically 
almost exclusive focus on restriction of total and 
saturated fat intake for reducing concentrations of the 
bad LDL cholesterol for cardiovascular risk prevention, 
to recognition of the importance of the different types 
of fat (saturated, polyunsaturated, monounsaturated, 
or trans-fatty acids), and to the relevance of the 
replacement nutrient (unsaturated fat or carbohydrates) 
when intake of saturated fat is reduced.1,2 However, our 
understanding of these issues is by no means complete. 
For example, are saturated fats or carbohydrates equally 
bad, or is one worse than the other for cardiovascular 
health? Questions remain, and these issues are still 
hotly debated, leaving many lost in the fog of the of 
the fat-versus-carbohydrate war. Meanwhile, the global 
relevance of dietary research mostly done in North 
American and European countries is unclear.
In The Lancet Diabetes & Endocrinology, investigators 
of the Prospective Urban–Rural Epidemiology (PURE) 
study weigh in on these issues, reporting the results of 
a cross-sectional analysis with a focus on intermediate 
cardiovascular risk markers: lipids and blood pressure.3 
With 125 287 participants enrolled from 18 countries 
across five continents, spanning a range of economic 
development, the findings suggest that a wider 
consideration of lipids—beyond LDL cholesterol—is 
important to capture the net effect of macronutrient 
substitutions. Together with an accompanying PURE 
study Article in The Lancet reporting on the link between 
macronutrients, mortality, and incident cardiovascular 
disease,4 the findings lead to two broad conclusions: 
unsaturated fat is more favourable than saturated fat, 
and saturated fat is more favourable than carbohydrates. 
However, several nuances of the study design restrict 
the causal inferences that can be made. Not only are 
the risk-factor analyses cross-sectional, but the study 
also raises a previously undescribed possibility of an 
interaction whereby changes in lipid concentrations 
related to macronutrient substitutions vary according to 
level of total and saturated fat intake. Therefore, because 
diet varied substantially between world regions (eg, the 
estimated mean saturated fat intake in China is 5·6% of 
total energy vs about 11% in North America and Europe3), 
pooling data across regions might be problematic. 
The notion that saturated fat is more favourable than 
carbohydrates is broadly in line with summary evidence 
from high-income countries showing that replacing 
saturated fat with carbohydrate is unlikely to help 
to reduce cardiovascular disease risk.1,2 Carbohydrate 
quality was not assessed in the PURE study, yet refined 
carbohydrate intake was likely to predominate in PURE 
populations, and to do so differentially across regions.3
Taken together across the two reports,3,4 the 
conclusions are provocative: first that the focus on a 
single lipid biomarker, LDL cholesterol, is misplaced, and 
second that the key dietary priority should be to reduce 
intake of carbohydrate, rather than total fat or saturated 
fat, worldwide. 
So what are the public health implications of these 
findings? The appraisal of whether a change in dietary 
guidance is warranted rests broadly on a body of evidence 
informed by different study designs within the so-called 
hierarchy-of-evidence framework, and with replication 
and consistency of findings. Against these criteria, 
strengths of the PURE study lie in its important and 
timely investigation across diverse global populations 
with varying diets, and bold attempts to standardise 
dietary assessment and a comprehensive range of 
lipid measurements. Limitations, in addition to those 
previously mentioned, include the inability to measure 
trans-fat intake and, with respect to the lipid and blood 
pressure analyses in particular, the cross-sectional design 
and the potential for residual confounding from an 
absence of adjustment for BMI or alcohol intake. The 
consideration of non-traditional lipid parameters is 
noteworthy, but their causal or meaningful predictive 
value over traditional lipid measures5,6 needs to be 
determined in different ethnic groups. 
Notable heterogeneity in nutrient and lipid 
associations also remains unexplained, thereby limiting 
the inference based on the averaged associations in 
the total study population. For example, the estimated 
effect of replacing saturated fat with polyunsaturated 
fat (by 3% energy) on the ratio of total cholesterol 
to HDL cholesterol was –0·38 in North America and 
Europe, 0·16 in South America, –0·07 in the Middle East, 
0·13 in south Asia, 0·06 in China, –0·15 in Malaysia, 
and 0·09 in Africa.3 The authors’ overall estimate was 
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0·059 (95% CI 0·041 to 0·078; p<0·0001). However, 
we calculated that the summary estimate could be 
–0·010 (95% CI –0·127 to 0·108; I²=93·0%) via random-
effects modelling, and thus the presented estimates are 
unstable. The authors appropriately attributed variation 
to different food sources, varying distributions of 
dietary consumption, and related dose responses,3,4 but 
other sources deserve consideration, including untested 
interactions by population characteristics (eg, obesity 
status7), and varying degrees of validity of dietary 
questionnaires and food-composition tables that were 
partly based on US databases.3 Possible confounding due 
to varying dietary patterns is also relevant. For example, 
refined carbohydrates could be consumed from white 
rice associated with salty fish consumption in some 
regions in Asia, but in North America and Europe they 
could be consumed from white bread, soft drinks, or 
confectionary, which are associated with an unhealthy 
lifestyle. Finally, diverse risk patterns of cardiovascular 
disease are likely to cause heterogeneous findings 
between populations—eg, higher haemorrhagic stroke 
risk than ischaemic stroke risk in low-income countries 
and vice versa in high-income countries.8
The PURE study offers a global perspective that 
fills an important research gap, for which the study 
investigators should be applauded. However, their 
cross-sectional evidence3 should be considered 
hypothesis generating, and their prospective findings4 
need to be replicated. The work should therefore 
act as a stimulus for further systematic appraisal of 
existing and new evidence, including randomised 
trials in low-income and middle-income countries. 
Acknowledging that nutritional trials for hard endpoints 
are especially challenging to undertake, prospective 
evidence combined with trials of intermediate risk 
markers could help with public health decision making 
to extend nutrient-based evidence to future dietary 
recommendations based on local foods, meals, and 
dietary patterns, and embracing the sociocultural 
environment. For now, despite some caveats, the 
PURE study’s findings broadly support the notion 
that reducing total fat intake may be unwarranted 
and that replacing saturated fat intake with (refined) 
carbohydrates is not a good recipe for cardiovascular 
health.
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